Gadoteridol Injectable Solution bulk supplier for pharma manufacturers

Gadoteridol Injectable Solution 0.5 mol/L Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 0.5 mol/L

Reference Brands: ProHance(US & EU)

Gadoteridol is a gadolinium-based contrast agent that enhances MRI images by increasing tissue radiopacity. It improves visualization of blood vessels, organs, and abnormalities, supporting accurate diagnosis. Benefits include high image clarity, rapid clearance, safety, and detailed imaging that aids effective neurological, cardiovascular, and musculoskeletal assessments worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Gadoteridol injectable solution, marketed as ProHance, is approved in the US by the FDA and in the EU via EMA for MRI contrast enhancement. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports swift approval, safe administration, and worldwide availability, enabling high-quality diagnostic imaging for neurological, cardiovascular, and musculoskeletal assessments globally.

Gadoteridol Injectable Solution — third party manufacturing & bulk supply

Gadoteridol Injectable Solution 0.5 mol/L is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Gadoteridol Injectable Solution is supplied as Injectable Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Gadoteridol Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Gadoteridol Injectable Solution →

Back to Listing

Frequently Asked Questions

Gadoteridol Injectable Solution is listed as Injectable Solution in 0.5 mol/L. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Gadoteridol Injectable Solution is referenced against ProHance(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.